Alkem Laboratories Limited has informed the Exchange regarding a press release dated September 25, 2023, titled "ALKEM enters into a co-development and license agreement with Biosergen AB".
Alkem Laboratories Limited has informed the Exchange regarding a press release dated September 25, 2023, titled "ALKEM enters into a co-development and license agreement with Biosergen AB".